Scientists find features of long COVID brain symptoms
A recent study conducted by the National Institutes of Health (NIH) sheds light on the biological and clinical features of neurological symptoms associated with...
One in ten older Americans has dementia, study finds
Cognitive impairment is a significant public health issue in the United States, especially for those aged 65 and above.
A recent study conducted by researchers...
Exercise for type 2 diabetes: What you need to know
Type 2 diabetes is a chronic condition that affects millions of people worldwide.
It is characterized by high blood sugar levels due to the body's...
Does obesity affect your cognitive ability?
A recent study published in PLOS Medicine has found that the links between cognitive ability and body mass index (BMI) may not be as...
COVID vaccination is not linked to cardiac arrest, study shows
A study conducted in Victoria, Australia, has found no association between out-of-hospital cardiac arrests and COVID-19 vaccines.
The study was published in the journal Circulation...
Over 50% of top selling Medicare drugs have low added benefit
Brand-name drugs sold in the United States are two to three times more expensive than in other countries, but many of the top-selling brand-name...
Scientists find the best treatment for metabolic liver disease
Metabolic surgery, also known as bariatric surgery, is a more effective treatment than medications and lifestyle changes for advanced non-alcoholic fatty liver disease.
This is...
Scientists find new cause of vision loss disease in older people
In a new study, researchers at Genentech have identified potential drug targets for age-related macular degeneration (AMD) through a study in Cell Genomics.
AMD affects...
Research discovers a hidden cause of dementia
A recent study conducted by researchers at Cedars-Sinai found that some patients diagnosed with behavioral-variant frontotemporal dementia (bvFTD) may actually have a treatable condition...
Latest diabetes drug may help prevent kidney and lung diseases
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a relatively new class of drugs that have been developed for the treatment of type 2 diabetes.
In recent...